Skip to main content


Fig. 1 | BMC Neurology

Fig. 1

From: Rebound of relapses after discontinuation of rituximab in a patient with MOG-IgG1 positive highly relapsing optic neuritis: a case report

Fig. 1

(a) Axial and (b) coronal T1-weighted magnetic resonance images demonstrating diffuse gadolinium enhancement and swelling along the right anterior and posterior optic nerve. c Longitudinal clinical course of recurrent optic neuritis. d Change of CD19+ B-lymphocytes (%) during rituximab treatment. e Change of MOG-IgG1 titers measured by a geometric mean fluorescence (G-mean) ratio of the MOG-expressing cells that bound to IgG1 using in-house flow cytometry (G-mean ratio = G-mean values of the patient’s sera / G-mean values of the healthy control)

Back to article page